Application | Comment | Organism |
---|---|---|
drug development | aminopeptidase N is a target for development of specific inhibitors | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(1S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate | IC50: 70 nM | Homo sapiens | |
(1S)-2-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate | IC50: 50 nM | Homo sapiens | |
(1S)-3-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-aminium acetate | IC50: 74 nM | Homo sapiens | |
(4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide | IC50: 7.7 nM | Homo sapiens | |
(4R)-4-([(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide | IC50: 2.1 nM | Homo sapiens | |
2-amino-2-phenylethanethiol | IC50: 25 nM | Homo sapiens | |
2-amino-3-(benzyloxy)propane-1-thiol | IC50: 56 nM | Homo sapiens | |
2-amino-3-(methylsulfanyl)propane-1-thiol | IC50: 20 nM | Homo sapiens | |
2-amino-3-(methylsulfinyl)propane-1-thiol | IC50: 21 nM | Homo sapiens | |
2-amino-3-(tert-butylsulfanyl)propane-1-thiol | IC50: 40 nM | Homo sapiens | |
2-amino-3-cyclohexylpropane-1-thiol | IC50: 45 nM | Homo sapiens | |
2-amino-3-phenylpropane-1-thiol | IC50: 30 nM | Homo sapiens | |
2-amino-4-(methylsulfanyl)butane-1-thiol | IC50: 11 nM | Homo sapiens | |
2-amino-4-(methylsulfinyl)butane-1-thiol | IC50: 20 nM | Homo sapiens | |
2-amino-4-methylpentane-1-thiol | IC50: 22 nM | Homo sapiens | |
3-amino-2-tetralones | - |
Homo sapiens | |
4-(2-amino-3-sulfanylpropyl)phenol | IC50: 45 nM | Homo sapiens | |
actinonin | natural competitive inhibitor, IC50: 0.0002 mM | Homo sapiens | |
amastatin | natural competitive inhibitor from Streptomyces sp. | Homo sapiens | |
anti-CD13 monoclonl antibody WM15 | inhibits enzyme activity, but not chemotactic activity | Homo sapiens | |
benzo[c]phenanthridine derivatives | natural inhibitors | Homo sapiens | |
bestatin | narural competitive inhibitor, inhibits enzyme activity, but not chemotactic activity, IC50: 0.007-0.0169 mM | Homo sapiens | |
beta-amino-alpha-hydroxyphenylbutanoic acid | i.e. AHPA, or AHPA-VAl, natural inhibitor isolated from Streptomyces neyagawaensis strain SL-387, IC50: 0.0012-0.0056 mM | Homo sapiens | |
betulinic acid | natural inhibitor isolated from birch tree, IC50: 0.0073 mM, a selectively apoptosis-inducing agent, overview | Homo sapiens | |
curcumin | natural inhibitor isolated from Curcuma longa, non-toxic, inhibits also tumor cell invasion and carcinogenesis in several organs, overview | Homo sapiens | |
ethyl D-cysteinate | strong, competitive inhibition, IC50: 350 nM | Homo sapiens | |
L-iso-glutamine inhibitors | diverse derivatives, IC50 of 0.016-0.053 mM | Homo sapiens | |
lapstatin | natural competitive inhibitor from Streptomyces sp., IC50: 0.0005 mM | Homo sapiens | |
leuhistin | natural inhibitor isolated from Bacilus laterosporus strain BMI156-14F1, strong, competitive inhibition | Homo sapiens | |
methyl (4R)-4-([(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino)-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinate | IC50: 0.9 nM | Homo sapiens | |
additional information | inhibitor binding site and mechanism, the enzyme is also inhibited by hydroxamate, carboxylate, sulfhydryl, and sulfodiimide derivatives of phosphoric acid, by beta-amino-thiol reagents, and alpha-aminophosphonates, overview | Homo sapiens | |
N-[(2S)-2-(([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)methyl)-4-methylpentanoyl]-L-phenylalanine | IC50: 2.3 nM | Homo sapiens | |
N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine | IC50: 5.3 nM | Homo sapiens | |
N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-benzylpropanoyl]phenylalanine | IC50: 1.5 nM | Homo sapiens | |
N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(4-bromobenzyl)propanoyl]-L-alanine | IC50: 1.9 nM | Homo sapiens | |
N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]alanine | IC50: 2.9 nM | Homo sapiens | |
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine | IC50: 4.8 nM | Homo sapiens | |
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-serine | IC50: 4.9 nM | Homo sapiens | |
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-threonine | IC50: 10.2 nM | Homo sapiens | |
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]glycine | IC50: 32.8 nM | Homo sapiens | |
N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-benzylpropanoyl]-L-phenylalanine | IC50: 4.2 nM | Homo sapiens | |
phebestin | natural competitive inhibitor from Streptomyces sp. | Homo sapiens | |
probestin | natural competitive inhibitor from Streptomyces sp., IC50: 0.00005 mM | Homo sapiens | |
psammaplin A | natural inhibitor isolated from a marine sponge, non-competitive, highly cytotoxic, IC50: 0.007-0.018 mM, overview | Homo sapiens | |
puromycin | natural inhibitor | Homo sapiens | |
[3-nitro-2-(2-nitrophenyl)-4-oxo-4H-chromen-8-yl]acetic acid | IC50: 0.025 mM | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cell surface | ectoenzyme | Homo sapiens | 9986 | - |
plasma membrane | type II membrane-bound ectoenzyme | Homo sapiens | 5886 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Zn2+ | zinc-metalloendopeptidase, contains the conserved zinc-binding motif HEXXH, i.e. HEALH-X18E, binds to the active site | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
bradykinin + H2O | Homo sapiens | - |
? | - |
? | |
interleukin-8 + H2O | Homo sapiens | - |
? | - |
? | |
Leu-enkephalin + H2O | Homo sapiens | - |
Leu + enkephalin | - |
? | |
additional information | Homo sapiens | the enzyme is involved in hydrolysis of neutral or basic amino acids from the N-terminus of bioactive peptides, or of amide or arylamide derivatives of amino acids, the enzyme promotes malignant angiogenesis/tumorigenesis, cell proliferation and tumor cell growth, and is involved in several diseases, e.g. inflammatory, overview, detailed catalytic machanism | ? | - |
? | |
Substance P + H2O | Homo sapiens | - |
? | - |
? | |
thymopentin + H2O | Homo sapiens | - |
? | - |
? | |
tuftsin + H2O | Homo sapiens | - |
? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | - |
Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
T-lymphocyte | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
bradykinin + H2O | - |
Homo sapiens | ? | - |
? | |
interleukin-8 + H2O | - |
Homo sapiens | ? | - |
? | |
Leu-enkephalin + H2O | - |
Homo sapiens | Leu + enkephalin | - |
? | |
additional information | the enzyme is involved in hydrolysis of neutral or basic amino acids from the N-terminus of bioactive peptides, or of amide or arylamide derivatives of amino acids, the enzyme promotes malignant angiogenesis/tumorigenesis, cell proliferation and tumor cell growth, and is involved in several diseases, e.g. inflammatory, overview, detailed catalytic machanism | Homo sapiens | ? | - |
? | |
Substance P + H2O | - |
Homo sapiens | ? | - |
? | |
thymopentin + H2O | - |
Homo sapiens | ? | - |
? | |
tuftsin + H2O | - |
Homo sapiens | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
dimer | homodimer, domain structure comprising cytosolic domain, transmembrane alpha-helix domain, N-glycosylation domain, polyproline and O-glycosylation domain, active site domain containing HEALH-X18E motif, and dimerization domain containing charged amino acids, overview | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
aminopeptidase N | - |
Homo sapiens |
APN | - |
Homo sapiens |
CD13 | - |
Homo sapiens |
More | the enzyme belongs to the peptidase family M1 | Homo sapiens |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.000019 | - |
probestin | - |
Homo sapiens | |
0.00023 | - |
leuhistin | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0000009 | - |
IC50: 0.9 nM | Homo sapiens | methyl (4R)-4-([(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino)-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinate | |
0.0000015 | - |
IC50: 1.5 nM | Homo sapiens | N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-benzylpropanoyl]phenylalanine | |
0.0000019 | - |
IC50: 1.9 nM | Homo sapiens | N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(4-bromobenzyl)propanoyl]-L-alanine | |
0.0000021 | - |
IC50: 2.1 nM | Homo sapiens | (4R)-4-([(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide | |
0.0000023 | - |
IC50: 2.3 nM | Homo sapiens | N-[(2S)-2-(([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)methyl)-4-methylpentanoyl]-L-phenylalanine | |
0.0000029 | - |
IC50: 2.9 nM | Homo sapiens | N-[(2S)-3-([(1R)-1-aminoethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]alanine | |
0.0000042 | - |
IC50: 4.2 nM | Homo sapiens | N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-benzylpropanoyl]-L-phenylalanine | |
0.0000048 | - |
IC50: 4.8 nM | Homo sapiens | N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine | |
0.0000049 | - |
IC50: 4.9 nM | Homo sapiens | N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-serine | |
0.0000053 | - |
IC50: 5.3 nM | Homo sapiens | N-[(2S)-3-([(1R)-1-amino-2-phenylethyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-alanine | |
0.0000077 | - |
IC50: 7.7 nM | Homo sapiens | (4R)-4-(hexanoylamino)-N-hydroxy-1-[(3,4,5-trimethoxyphenyl)carbonyl]-L-prolinamide | |
0.0000102 | - |
IC50: 10.2 nM | Homo sapiens | N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]-L-threonine | |
0.000011 | - |
IC50: 11 nM | Homo sapiens | 2-amino-4-(methylsulfanyl)butane-1-thiol | |
0.00002 | - |
IC50: 20 nM | Homo sapiens | 2-amino-4-(methylsulfinyl)butane-1-thiol | |
0.00002 | - |
IC50: 20 nM | Homo sapiens | 2-amino-3-(methylsulfanyl)propane-1-thiol | |
0.000021 | - |
IC50: 21 nM | Homo sapiens | 2-amino-3-(methylsulfinyl)propane-1-thiol | |
0.000022 | - |
IC50: 22 nM | Homo sapiens | 2-amino-4-methylpentane-1-thiol | |
0.000025 | - |
IC50: 25 nM | Homo sapiens | 2-amino-2-phenylethanethiol | |
0.00003 | - |
IC50: 30 nM | Homo sapiens | 2-amino-3-phenylpropane-1-thiol | |
0.0000328 | - |
IC50: 32.8 nM | Homo sapiens | N-[(2S)-3-([(R)-amino(phenyl)methyl](hydroxy)phosphoryl)-2-(biphenyl-4-ylmethyl)propanoyl]glycine | |
0.00004 | - |
IC50: 40 nM | Homo sapiens | 2-amino-3-(tert-butylsulfanyl)propane-1-thiol | |
0.000045 | - |
IC50: 45 nM | Homo sapiens | 2-amino-3-cyclohexylpropane-1-thiol | |
0.000045 | - |
IC50: 45 nM | Homo sapiens | 4-(2-amino-3-sulfanylpropyl)phenol | |
0.00005 | - |
IC50: 50 nM | Homo sapiens | (1S)-2-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate | |
0.00005 | - |
natural competitive inhibitor from Streptomyces sp., IC50: 0.00005 mM | Homo sapiens | probestin | |
0.000056 | - |
IC50: 56 nM | Homo sapiens | 2-amino-3-(benzyloxy)propane-1-thiol | |
0.00007 | - |
IC50: 70 nM | Homo sapiens | (1S)-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethanaminium acetate | |
0.000074 | - |
IC50: 74 nM | Homo sapiens | (1S)-3-methyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butan-1-aminium acetate | |
0.0002 | - |
natural competitive inhibitor, IC50: 0.0002 mM | Homo sapiens | actinonin | |
0.00035 | - |
strong, competitive inhibition, IC50: 350 nM | Homo sapiens | ethyl D-cysteinate | |
0.0005 | - |
natural competitive inhibitor from Streptomyces sp., IC50: 0.0005 mM | Homo sapiens | lapstatin | |
0.0012 | 0.0056 | i.e. AHPA, or AHPA-VAl, natural inhibitor isolated from Streptomyces neyagawaensis strain SL-387, IC50: 0.0012-0.0056 mM | Homo sapiens | beta-amino-alpha-hydroxyphenylbutanoic acid | |
0.007 | 0.0169 | narural competitive inhibitor, inhibits enzyme activity, but not chemotactic activity, IC50: 0.007-0.0169 mM | Homo sapiens | bestatin | |
0.007 | 0.018 | natural inhibitor isolated from a marine sponge, non-competitive, highly cytotoxic, IC50: 0.007-0.018 mM, overview | Homo sapiens | psammaplin A | |
0.0073 | - |
natural inhibitor isolated from birch tree, IC50: 0.0073 mM, a selectively apoptosis-inducing agent, overview | Homo sapiens | betulinic acid | |
0.016 | 0.053 | diverse derivatives, IC50 of 0.016-0.053 mM | Homo sapiens | L-iso-glutamine inhibitors | |
0.025 | - |
IC50: 0.025 mM | Homo sapiens | [3-nitro-2-(2-nitrophenyl)-4-oxo-4H-chromen-8-yl]acetic acid |